The PE Ratio as of November 2024 (TTM) for Checkpoint Therapeutics, Inc. (CKPT) is -2.05

According to Checkpoint Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.05. This represents a change of 7.51% compared to the average of -1.91 of the last 4 quarters.

Checkpoint Therapeutics, Inc. (CKPT) Historical PE Ratio (quarterly & annually)

How has CKPT PE Ratio performed in the past?

The mean historical PE Ratio of Checkpoint Therapeutics, Inc. over the last ten years is -4.04. The current -2.05 PE Ratio has changed 4.97% with respect to the historical average. Over the past ten years (40 quarters), CKPT's PE Ratio was at its highest in in the December 2022 quarter at -0.52. The PE Ratio was at its lowest in in the June 2015 quarter at -21.79.

Checkpoint Therapeutics, Inc. (CKPT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Checkpoint Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Checkpoint Therapeutics, Inc. (CKPT) Average PE Ratio

How has CKPT PE Ratio performed in the past?

The current PE Ratio of Checkpoint Therapeutics, Inc. (CKPT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Checkpoint Therapeutics, Inc. (CKPT) PE Ratio vs. Peers

How is CKPT’s PE Ratio compared to its peers?

Checkpoint Therapeutics, Inc.’s PE Ratio is less than Mustang Bio, Inc. (-0.32), less than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than Fortress Biotech, Inc. (-0.62), less than Kodiak Sciences Inc. (-1.70), less than Fortress Biotech, Inc. (-0.62), less than Avenue Therapeutics, Inc. (-0.23), less than Pieris Pharmaceuticals, Inc. (-1.39), less than Aileron Therapeutics, Inc. (-1.83), less than CytomX Therapeutics, Inc. (5.48), greater than Instil Bio, Inc. (-2.26), greater than Neoleukin Therapeutics, Inc. (-5.86), less than Spero Therapeutics, Inc. (21.41), greater than Assembly Biosciences, Inc. (-2.34), less than Achilles Therapeutics plc (-0.64), less than Cue Biopharma, Inc. (-1.17), greater than Medicenna Therapeutics Corp. (-2.32), greater than XOMA Corporation (-11.81), greater than ZIVO Bioscience, Inc. (-5.20), less than Lumos Pharma, Inc. (-1.03),

Build a custom stock screener for Checkpoint Therapeutics, Inc. (CKPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Checkpoint Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Checkpoint Therapeutics, Inc. (CKPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Checkpoint Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.